As of 2025-10-27, the Relative Valuation of Regeneron Pharmaceuticals Inc (REGN) is 593.47 USD. This relative valuation is based on P/E multiples. With the latest stock price at 577.95 USD, the upside of Regeneron Pharmaceuticals Inc based on Relative Valuation is 2.7%.
The range of the Relative Valuation is 579.67 - 612.40 USD.
| Range | Selected | |
| Trailing P/E multiples | 13.8x - 14.0x | 13.9x |
| Forward P/E multiples | 14.1x - 14.4x | 14.2x |
| Fair Price | 579.67 - 612.40 | 593.47 |
| Upside | 0.3% - 6.0% | 2.7% |
| Date | P/E |
| 2025-10-24 | 13.74 |
| 2025-10-23 | 13.69 |
| 2025-10-22 | 13.90 |
| 2025-10-21 | 13.77 |
| 2025-10-20 | 13.71 |
| 2025-10-17 | 13.74 |
| 2025-10-16 | 13.53 |
| 2025-10-15 | 13.70 |
| 2025-10-14 | 13.61 |
| 2025-10-13 | 13.26 |
| 2025-10-10 | 13.42 |
| 2025-10-09 | 13.55 |
| 2025-10-08 | 13.40 |
| 2025-10-07 | 13.86 |
| 2025-10-06 | 13.92 |
| 2025-10-03 | 14.26 |
| 2025-10-02 | 14.26 |
| 2025-10-01 | 14.26 |
| 2025-09-30 | 13.37 |
| 2025-09-29 | 13.33 |
| 2025-09-26 | 13.41 |
| 2025-09-25 | 13.21 |
| 2025-09-24 | 13.72 |
| 2025-09-23 | 13.50 |
| 2025-09-22 | 14.16 |
| 2025-09-19 | 14.07 |
| 2025-09-18 | 14.23 |
| 2025-09-17 | 13.92 |
| 2025-09-16 | 13.67 |
| 2025-09-15 | 13.61 |
| 2025-09-12 | 13.31 |
| 2025-09-11 | 13.51 |
| 2025-09-10 | 13.21 |
| 2025-09-09 | 13.23 |
| 2025-09-08 | 13.28 |
| 2025-09-05 | 13.63 |
| 2025-09-04 | 13.48 |
| 2025-09-03 | 13.40 |
| 2025-09-02 | 13.74 |
| 2025-08-29 | 13.80 |
| 2025-08-28 | 13.78 |
| 2025-08-27 | 13.95 |
| 2025-08-26 | 13.97 |
| 2025-08-25 | 13.61 |
| 2025-08-22 | 14.01 |
| 2025-08-21 | 14.22 |
| 2025-08-20 | 14.05 |
| 2025-08-19 | 13.59 |
| 2025-08-18 | 13.64 |
| 2025-08-15 | 13.80 |